The GISAID Initiative promotes the rapid sharing of data from all influenza viruses and the coronavirus causing COVID-19. This includes genetic sequence and related clinical and epidemiological data associated with human viruses, and geographical as well as species-specific data associated with avian and other animal viruses, to help researchers understand how viruses evolve and spread during epidemics and pandemics.
Company Details
- Employees
- 11
- Founded
- 2008
- Address
- Los Angeles , Us
- Industry
- Public Health
- NAICS
-
Administration of Public Health Programs
- Website
- https://www.gisaid.org/
- HQ
- Los Angeles
- Competitors
- Dosimagem, Microsoma, CareerReactor, A*STAR Bioinformatics Institute (A*STAR BII), GDR CNRS ResaFlu, GIHSN | Global Influenza Hospital Surveillance Network, Tomazin Law Group, LLP, International Society for Infectious Diseases, Merck Group, WHO Collaborating Centre for Reference and Research on Influenza.
The Gisaid Initiative Questions
The Gisaid Initiative's website is https://www.gisaid.org/
The Gisaid Initiative's LinkedIn profile is https://www.linkedin.com/company/gisaid
The Gisaid Initiative has
11 employees.
View email and phone details for 11
employees at The Gisaid Initiative.
The Gisaid Initiative's industry is
Public Health
The Gisaid Initiative's top competitors are
Dosimagem,
Microsoma,
Careerreactor,
A*star Bioinformatics Institute (A*star Bii),
Gdr Cnrs Resaflu,
Gihsn | Global Influenza Hospital Surveillance Network,
Tomazin Law Group, Llp,
International Society For Infectious Diseases,
Merck Group,
Who Collaborating Centre For Reference And Research On Influenza.
The Gisaid Initiative's categories are Public Health
The Gisaid Initiative's founding year is 2008
